Health Care — 8-Day Rolling Flow

Data through 0501 close · 47 constituents · Automated pipeline · Anti Narrative Platform

Opening

Health Care is distributing broadly. Of 47 tracked constituents, 31 printed BEARISH Layer 1 signals on 05/01 against just 13 BULLISH — a 2.4:1 bear skew that marks one of the more lopsided single-day readings in the rolling window. The bifurcation runs along a clean line: pharma names with strong earnings catalysts (LLY +3.07%, MRK +2.73%, NVO +3.93%) are absorbing capital, while devices (SYK -6.47%, BSX -1.93%, MDT -1.20%), managed care (CI -2.64%, UNH -0.46%), and diversified pharma without fresh catalysts (ABBV -2.23%, AMGN -4.75%, BMY -3.91%) are leaking. The SYK -6.47% post-earnings selloff extends the earnings bifurcation regime — operational misses get sold aggressively while clean prints get bid (AAPL template).

Regime Dashboard

┌─────────────────────────────────────────────────────────────────┐
│ REGIME DASHBOARD — 0501 CLOSE                                   │
├─────────────────────────────────────────────────────────────────┤
│ FED REGIME:        NEUTRAL HOLD 3.50-3.75% (8-4 vote)          │
│ RATE REGIME:       10Y upper zone — yields stretched            │
│ DXY:               ~98.12 — mid-zone, HARD BLOCK receded       │
│ OIL:               ~$104+ DOMINANT — reflation regime           │
│ ISM PMI:           52.7 EXPANSION (3rd month)                   │
│ ISM Prices Paid:   78.3 — input cost pressure                   │
│ HYG:               $80.06 — LOWER bound, gate CLEAR             │
│ 200DMA:            SPX ABOVE (+520 pts stretch)                 │
│ EARNINGS:          BIFURCATION — clean prints bid, misses sold  │
│ FOM SENTIMENT:     69.6 GREED (04/30) — +13.9 1D rebound       │
│ VIX:               16.98 cash (inside-day) — sub-17 bullish     │
│ CONVERGENCE:       +1 NET BULL (14 bull / 12 bear, compressed)  │
│ FRAGILITY:         3-of-4 flags HELD — Tier 2 max               │
├─────────────────────────────────────────────────────────────────┤
│ SECTOR IMPLICATION: Fed NEUTRAL + ISM EXPANSION = healthcare    │
│ supported structurally, but 3-of-4 fragility + compressed       │
│ convergence = no new aggressive longs. Pharma bid selective.    │
│ Devices/MCOs distributing. Oil $104+ = cost headwind for        │
│ hospitals & providers.                                          │
└─────────────────────────────────────────────────────────────────┘

Breadth Snapshot (0501)

Top-Flow Ticker Table (0501)

Pharma & Biotech

Devices & Life Sciences

Managed Care & Providers

Rolling Scorecard (Layer 1 — 8 Sessions)

Each cell shows the Layer 1 classification for the trading session. B = Buy (price up + volume), S = Sell (price down + volume), N = Neutral, — = no DP data that session. Columns are the last 8 trading sessions (04/22 → 05/01). Window capped at 10.

Rolling Net Directional Flow (8 Sessions)

Net flow = AtAsk − AtBid (positive = demand, negative = supply). Values in $M. Red cells > -$100M; green cells > +$100M.

Tier Assignments

Distribution Watch (Persistent Bear)

Rule 5/10 Watch

Rule 5 (Price Action Is The Signal) and Rule 10 (Labels Lie — Price Doesn't) flag tickers where darkpool labels diverge from Layer 1 price direction. On a fast-tape day like 05/01, label reliability is LOW across the board. Key divergences worth noting:

Synthesis

Health Care is bifurcating along an earnings-quality fault line. The pharma names with clean fundamental catalysts — LLY's obesity franchise, MRK's oncology pipeline, NVO's GLP-1 narrative — are absorbing institutional capital while the rest of the sector distributes. The 31-of-47 bearish breadth on 05/01 is not a blanket sell signal; it is the market repricing the sector around a narrow set of winners. LLY's +9.8% earnings pop on 04/30 followed by +3.07% continuation on 05/01 with a STRONG accumulation ladder is the clearest Tier 1 signal in the sector.

The devices subsector is the weakest cohort. SYK's -6.47% post-earnings crash extends the bifurcation regime template: AAPL +3.24% for clean execution, SYK -6.47% for capex disappointment. BSX has been distributing for 4 consecutive sessions (04/24-04/29) with a STRONG distribution ladder. ABT and MDT both carry MODERATE distribution ladders. This is not rotation within devices — it is broad institutional exit from the surgical/device complex, likely driven by oil-at-$104 input cost concerns bleeding into hospital capex budgets.

Managed care is the most interesting subsector to watch. UNH carries the strongest rolling scorecard (4B-1S) but flipped BEAR on 05/01 with negative GEX (-2.88). CNC had a massive recovery (+13.9% on 04/28, +8.9% on 04/29) but has now printed 2 consecutive SELL sessions. ELV's 4B-2S rolling is weakening. The MCO recovery trade that began in late April appears to be exhausting, which aligns with the regime-level HYG divergence building against equities.

The sector-level read for positioning: Health Care as a sector is not investable as a basket — XLV will be dragged by the 31 bearish names even if LLY rallies. The correct expression is single-name pharma longs (LLY, MRK, GILD as Tier 2 candidates) paired with avoidance of devices and fading MCO momentum. Fragility is 3-of-4 at the index level, so even the Tier 1 names carry Tier 2 sizing constraints per Rule 9. No new aggressive sector longs until breadth improves above 50% bullish or fragility flags clear.

Oil at $104+ is the underappreciated headwind. Hospitals, device companies, and providers all face higher energy and logistics costs. The ISM Prices Paid at 78.3 confirms input cost pressure across the economy. Pharma is relatively insulated (high margins absorb cost pressure) but devices and providers are not. This macro overlay reinforces the pharma-vs-everything-else bifurcation pattern.